GSK-110871

Study Sponsor: GSK

Study Title

Immunogenicity and safety study of a booster dose of GSK Biologicals’ meningococcal vaccine 134612 given at 12-15 months of age or at 15-18 months of age (co-administered with Infanrix®) in primed healthy toddlers.

Medicine or Vaccine (generic name)

Meningococcal Serogroups A, C, W-135 and Y-Tetanus Toxoid Conjugate Vaccine

Sponsor Identification Number

110871

Trial Registry Identification Number(#'s)

NCT00614614

Medical Condition

Infections, Meningococcal

Phase

Phase 3

Link to GSK Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=110870

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT00614614

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

This is a booster study to 110870. The results are summarised with 110870 on the GSK Study Register.

Date Added to this Site

January 2017